Nonoperating Income (Expense) of Achilles Therapeutics plc from 31 Dec 2019 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Achilles Therapeutics plc quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2019 to 30 Jun 2024.
  • Achilles Therapeutics plc Nonoperating Income (Expense) for the quarter ending 30 Jun 2024 was $1,427,000, a 18% increase year-over-year.
  • Achilles Therapeutics plc annual Nonoperating Income (Expense) for 2023 was $6,081,000, a 17% decline from 2022.
  • Achilles Therapeutics plc annual Nonoperating Income (Expense) for 2022 was $7,318,000, a 134% increase from 2021.
  • Achilles Therapeutics plc annual Nonoperating Income (Expense) for 2021 was $3,133,000, a 490% increase from 2020.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Achilles Therapeutics plc Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $1,427,000 +$215,000 +18% 01 Apr 2024 30 Jun 2024 6-K 14 Aug 2024 2024 Q2
Q2 2023 $1,212,000 -$2,059,000 -63% 01 Apr 2023 30 Jun 2023 6-K 14 Aug 2024 2024 Q2
Q2 2022 $3,271,000 01 Apr 2022 30 Jun 2022 6-K 04 Aug 2023

Achilles Therapeutics plc Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $6,081,000 -$1,237,000 -17% 01 Jan 2023 31 Dec 2023 20-F 04 Apr 2024 2023 FY
2022 $7,318,000 +$4,185,000 +134% 01 Jan 2022 31 Dec 2022 20-F 04 Apr 2024 2023 FY
2021 $3,133,000 +$2,602,000 +490% 01 Jan 2021 31 Dec 2021 20-F 04 Apr 2024 2023 FY
2020 $531,000 +$746,000 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023 2022 FY
2019 $215,000 01 Jan 2019 31 Dec 2019 20-F 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.